Kiromic BioPharma Forum: Community User: Summer.76

🍀

KIROMIC BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) https://www.marketscreener.com/quote/stock/KIROMIC-BIOPHARMA-INC-113902312/news/KIROMIC-BIOPHARMA-INC-nbsp-Entry-into-a-Material-Definitive-Agreement-Financial-Statements-and-35636960/

https://www.marketscreener.com/quote/stock/KIROMIC-BIOPHARMA-INC-113902312/news/Kiromic-BioPharma-nbsp-KRBP-Presenting-at-July-2021-Gamma-Delta-T-Cell-Summit-to-Showcase-Our-Off-35632062/

Kiromic Announces Expansion of In-House Cell therapy cGMP Manufacturing Facility and the Appointment of Industry Veteran Ignacio Núñez as Chief Operating and Manufacturing Officer https://www.businesswire.com/news/home/20210607005260/en/Kiromic-Announces-Expansion-of-In-House-Cell-therapy-cGMP-Manufacturing-Facility-and-the-Appointment-of-Industry-Veteran-Ignacio-N%C3%BA%C3%B1ez-as-Chief-Operating-and-Manufacturing-Officer — Expansion of in-house cGMP manufacturing facility to provide support to the Company's clinical trials. Therapeutic doses expected to be ready for first in-human dosing in 3Q-2021. — Mr. Ignacio Núñez, a 20-year industry veteran in global operations and manufacturing, is joining the Kiromic team to take the company to the next level and to scale up cGMP manufacturing capabilities internally. ...

Fuuuck warum sinkt es jetzt

Bin jetzt mit 2000 Anteilen bei 8 Dollar eingestiegen

Kiromic BioPharma : Announces FDA IND Submission First-In-Human, AI derived Off-The-Shelf IsoMesothelin Gamma Delta CAR T-cell Therapy, 30 Days Before the End of the Second Quarter https://www.marketscreener.com/quote/stock/KIROMIC-BIOPHARMA-INC-113902312/news/Kiromic-BioPharma-nbsp-Announces-FDA-IND-Submission-First-In-Human-AI-derived-Off-The-Shelf-IsoMe-33337489/ Kiromic achieves key milestone for this first-in-human Phase 1 clinical trial with a target derived by Kiromic’s AI platform.

Kiromic Announces Identification of Novel Targets for Allogeneic CAR Gamma Delta T-cell Therapy in Solid Tumors Utilizing Kiromic’s Proprietary Artificial Intelligence Engine https://www.businesswire.com/news/home/20210521005209/en/Kiromic-Announces-Identification-of-Novel-Targets-for-Allogeneic-CAR-Gamma-Delta-T-cell-Therapy-in-Solid-Tumors-Utilizing-Kiromic%E2%80%99s-Proprietary-Artificial-Intelligence-Engine

Nice. Starten die jetzt schon mit Phase 2 oder brauchen die dafür erstmal grünes Licht ?

Kiromic Announces FDA IND Submission Forty-Five Days before the end of the Second Quarter: First-In-Human, Off-The-Shelf Chimeric PD1 Switch Receptor - Gamma Delta T-cell Therapy https://www.businesswire.com/news/home/20210517005496/en/Kiromic-Announces-FDA-IND-Submission-Forty-Five-Days-before-the-end-of-the-Second-Quarter-First-In-Human-Off-The-Shelf-Chimeric-PD1-Switch-Receptor---Gamma-Delta-T-cell-Therapy Kiromic achieves key milestone for this first in human phase 1 clinical trial

Hört sich sehr vielversprechend an, ich glaube ich steige am Montag ein, will nichts verpassen

Kiromic BioPharma reports Q1 results https://seekingalpha.com/news/3696721-kiromic-biopharma-reports-q1-results • Kiromic BioPharma (NASDAQ:KRBP): Q1 GAAP EPS of -$0.53. • Cash and cash equivalents of $7.34M

Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress https://www.businesswire.com/news/home/20210514005463/en/Kiromic-BioPharma-Reports-First-Quarter-2021-Financial-Results-and-Continued-Corporate-Progress Upcoming Investigational New Drug Application Submissions Facility Expansion in Houston, TX Leon Office, Asia, Strategic Marketing Agreement SBA Loan Extinguishment Research Grant Agreement with University of Texas MD Anderson Cancer Center ...

Hier dürfte sich Kiromic nachher präsentieren: https://www.benzinga.com/events/small-cap/global/#agenda BENZINGA GLOBAL SMALL CAP CONFERENCE

Ich werde sie noch weiter beobachten und dann entscheiden. Die Vola wird noch ne Menge Möglichkeiten zum Einstieg bieten.

Geil man kann bestimmt noch bei 2 Dollar einsteigen